Literature DB >> 6871068

Prediction of optimum oral theophylline dose in patients with obstructive airways disease.

D R Taylor, C D Kinney, D G McDevitt.   

Abstract

The hypothesis that a logarithmic correlation exists between the plasma theophylline concentrations 6 h after a test dose C(6) and the maintenance dose calculated to achieve a desired drug concentration during chronic oral administration (DM,CALC) was tested. A nomogram based on this relationship was evaluated as a means of predicting the optimum dose of theophylline in 14 patients with obstructive airways disease (DM,PRED). Each patient was given 5 mg/kg theophylline intravenously (i.v.) and plasma theophylline concentrations were measured for 12 h thereafter including one exactly 6 h after commencing the i.v. infusion C(6). Pharmacokinetic parameters derived from the plasma concentration-time curve were used to establish DM,CALC for a concentration of 10 micrograms/ml. DM,PRED was obtained from the nomogram using both the optimum and the actual values for C(6). Subsequently oral sustained-release theophylline was administered and the dose adjusted to establish a trough concentration of approximately 10 micrograms/ml. This dose was then corrected arithmetically, assuming a linear relationship between dose and plasma level, to represent that required to achieve a plasma concentration of exactly 10 micrograms/ml (DM,ACT). The correlation between C(6) and log DM,CALC was confirmed (r = 0.97 P less than 0.001), validating the hypothesis. DM,ACT was found to correlate significantly with DM,PRED (r = 0.90, P less than 0.01) substantiating the value of the nomogram. In nine of the 14 patients, DM,ACT corresponded satisfactorily to DM,PRED. In the remaining five, for whom DM,ACT lay outside the 95% confidence limits for the predicted dose, DM,PRED in general underestimated DM,ACT, an advantage in a drug with a low therapeutic index. The predictive error for DM,PRED was lower than that for DM,CALC, and the bias using either method was not significant. The results suggest that a single plasma theophylline assay following a test dose, and the nomogram may be useful in simplifying optimal theophylline administration.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6871068      PMCID: PMC1427920          DOI: 10.1111/j.1365-2125.1983.tb01551.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  11 in total

1.  Dose-dependent kinetics of theophylline disposition in asthmatic children.

Authors:  M Weinberger; E Ginchansky
Journal:  J Pediatr       Date:  1977-11       Impact factor: 4.406

2.  Measurement of theophylline in plasma by high performance liquid chromatography.

Authors:  J G Kelly; W J Leahey
Journal:  Br J Clin Pharmacol       Date:  1976-10       Impact factor: 4.335

Review 3.  Clinical pharmacokinetics of theophylline.

Authors:  R I Ogilvie
Journal:  Clin Pharmacokinet       Date:  1978 Jul-Aug       Impact factor: 6.447

4.  Rational intravenous doses of theophylline.

Authors:  P A Mitenko; R I Ogilvie
Journal:  N Engl J Med       Date:  1973-09-20       Impact factor: 91.245

5.  Pharmacokinetics of theophylline. Application to adjustment of the clinical dose of aminophylline.

Authors:  J W Jenne; M S Wyze; F S Rood; F M MacDonald
Journal:  Clin Pharmacol Ther       Date:  1972 May-Jun       Impact factor: 6.875

6.  Hypothesis for the individualisation of drug dosage.

Authors:  J R Koup; C M Sack; A L Smith; M Gibaldi
Journal:  Clin Pharmacokinet       Date:  1979 Nov-Dec       Impact factor: 6.447

7.  Some suggestions for measuring predictive performance.

Authors:  L B Sheiner; S L Beal
Journal:  J Pharmacokinet Biopharm       Date:  1981-08

8.  Pharmacokinetics of sustained release theophylline in low and high multidose regimens.

Authors:  G H Koëter; J H Jonkman; K de Vries; R Schoenmaker; J E Greving; R A de Zeeuw
Journal:  Br J Clin Pharmacol       Date:  1981-11       Impact factor: 4.335

9.  Theophylline bioavailability following chronic dosing of an elixir and two solid dosage forms.

Authors:  D D Shen; M Fixley; D L Azarnoff
Journal:  J Pharm Sci       Date:  1978-07       Impact factor: 3.534

10.  Dose-dependency of theophylline clearance and protein binding.

Authors:  J A Fleetham; C E Bird; K Nakatsu; R D Wigle; P W Munt
Journal:  Thorax       Date:  1981-05       Impact factor: 9.139

View more
  3 in total

1.  Prediction of maintenance oral theophylline dosage using single oral doses in patients with obstructive airways disease.

Authors:  D R Taylor; C D Kinney; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1983-11       Impact factor: 4.335

2.  Theophylline dose prediction.

Authors:  D T Beswick; R E Cullen; G W Rylance
Journal:  Arch Dis Child       Date:  1984-08       Impact factor: 3.791

3.  A comparison of the accuracy of a least squares regression, a Bayesian, Chiou's and the steady-state clearance method of individualising theophylline dosage.

Authors:  S F Hurley; J J McNeil
Journal:  Clin Pharmacokinet       Date:  1988-05       Impact factor: 6.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.